Learning Discoveries Psychological Services
Rosemary Boon
Registered Psychologist
M.A.(Psych), Grad. Dip. Ed. Studies (Sch.Counsel), Grad. Dip. Ed., B.Sc., MAPS

Telephone and Facsimile:
Sydney (+61 2) 9727 5794


P.O. Box 7120
Bass Hill NSW 2197


Home / About L.D.P.S & Services Offered / Learning Disabilities / Attention Deficit/Hyperactivity Disorder / The Learning Pyramid /
Articles, Papers & Information Sheets / Classes & Workshops / Related Links & Resources & References

QEEG and Neurofeedback - diagnostic and training modalities for the enhancement of CNS functioning in ADHD and other disorders

Rosemary Boon, Psychologist, Ph/Fax (02) 9727 5794 http://home.iprimus.com.au/rboon

Attention Deficit/Hyperactivity Disorder (ADHD), learning disabilities, autism and mental illness including depression, anxiety and suicide have all increased at an alarming rate over the past decades. This is cause for great concern amongst health professionals/authorities worldwide and the public [1-4]. While the effect of these disorders are far reaching for the individual and their quality of life, they have major impacts on society as a whole. They have a stratifying socio-economic impact with associated losses in productivity, increased costs of medical care and education, escalating substance abuse, criminality and the social costs of treating all these ailments [5]. ADHD has recently made news headlines on account of concerns of misdiagnosis, possible over-prescription of Ritalin and its untested long-term effects on developing brains.

Research has shown that ADHD is often accompanied by other brain-related problems. The findings of genetic studies indicate a strong correlation and a genetic link between ADHD and a number of other disorders. These disorders include: conduct disorder, adult antisocial personality disorder, criminality, mood disorders (anxiety and depression), substance abuse and obsessive-compulsive disorder In particular, the combination of ADHD and Conduct Disorder is a strong predictor of adult Antisocial Personality Disorder, Criminality and substance abuse [6-9]. Children may, and often do, have multiple disorders coexisting with their ADHD at the time of initial clinical presentation. Such comorbid disorders may interact with and exacerbate each other, resulting in different developmental courses and adolescent and adult outcome, have a somewhat different pattern of causes, and even a different response to treatment, than just ADD alone. [10-13].

It is not uncommon to find a family where one child has ADHD, another dyslexia or learning difficulties, a third dyspraxia and it is quite common for an individual to suffer from more than one of these conditions. In fact:

Self-esteem problems are both primary and secondary in children with ADD. These children do not develop an appropriate self-concept and have difficulty relating to their family and peers. Feelings of inadequacy, anxiety and depression are therefore more common. Only 11% of ADHD children are free as adults from any psychiatric diagnosis, function well and have no significant symptoms of their disorder [16-19].

Psychostimulant medication which is the mainstream treatment for ADHD alters the biochemical interactions in the brain in an attempt to mask symptoms and is not a cure but rather akin to taking aspirin for pain management. These pharmacological agents frequently fail to produce the desired long-term effects and lead to unwanted and unacceptable side effects in as many as 30-40% of ADHD patients. In 20-50% of patients, unacceptable side effects result in discontinuation of treatment and the underlying neurological and physiological symptoms remain unaddressed [20]. As early as 1978, Barkley and Cunningham found that (1) "stimulant drugs appear to have little, if any impact on the academic performance of hyperkinetic children; (2) the major effect of the stimulant drugs is on the short-term manageability of hyperkinetic behaviour; (3) any positive behavioural response to the stimulants is not likely to be accompanied by improvements in academic performance" [21].

Swanson et al. in a comprehensive examination of 341 reviews of the use of medication concluded that hyperactivity and attending might improve amongst 60 to 75% of children. For some that may be a huge improvement, however, their concentration, learning ability and cognitive skills may not improve [22]. This relatively poor outlook is contrary to what is required for adaptive learning and may partially be explained by the findings that stimulant medication may actually decrease responsiveness to positive rewards, while increasing responsiveness to punishment [23]. The limitations of psychostimulant medications have led to the widespread adoption in clinical practice of alternative and adjunctive modalities. While short-term use can be very useful, it can be argued that medication may in essence reduce the ability of the brain to self regulate and promote normal functioning. Since all learning and behaviour starts in the actual physical functioning of the brain, assessing brain function whenever learning or behavioural disorders are suspected, is therefore of paramount importance.

Many psychiatrists, paediatricians and psychologists involved in the diagnosis of learning disorders and ADHD are unaware of a significant body of research which supports the use of topometric quantitative electroencephalographic (QEEG) analysis as a diagnostic tool for differentiating between organic and functional brain disorders including learning difficulties, ADHD, schizophrenia, epilepsy, cerebral atrophy associated with alcohol abuse, depression and anxiety [24]. Psychophysiologists have established normative QEEG databases. The differences in brain wave patterns revealed in these comparisons point to subtypes of ADHD that are not documented in the DSM-IV [25-28]. Studies of QEEG patterns of ADHD children and adults are consistent with findings revealed by PET, fMRI, SPECT and other neuroimaging studies [28-32]. More recently, research from SPECT brain studies by Daniel Amen and his colleagues have identified six subtypes of ADHD which correlate to QEEG patterns found in individuals with ADD [33-34].Thus, topometric QEEG analysis is a powerful adjunct to psychometric assessment in this area.

The topometric QEEG is an objective and effective tool that uses digital technology to measure electrical patterns at the surface of the scalp which primarily reflect cortical activity or "brainwaves". A multi-electrode recording of brainwave activity is made under different conditions (eyes closed, eyes open, and during cognitive challenges such as reading and arithmetic) and converted into numbers by a computer. These numbers are then statistically analysed and compared to a database. Such comparisons allow the clinician to determine whether or not brain functioning is abnormal, to what degree, in what locations and in which frequency band. The procedure has the advantage of being non-invasive and requires no more than a few hours administration.

Neurologist John Hughes from the Department of Neurology, University of Illinois School of Medicine and psychiatrist E. Roy John from the Department of Psychiatry, New York University Medical Centre state in their 1999 paper titled "Conventional and Quantitative Electroencephalography in Psychiatry": "New three-dimensional QEEG imaging methods offer an economical alternative to other functional brain imaging modalities…..During the last decade more than 500 EEG and QEEG papers have reported well designed studies, concurring that EEG and QEEG abnormalities are found in a high proportion of psychiatric patients. Conditions such as anxiety disorder, depression, dementia, obsessive-compulsive disorder, schizophrenia, learning disabilities and attention deficit disorder with and without hyperactivity are now understood to involve interactions between brain dysfunctions or altered neuroanatomical structure and environmental influences. An overview of the findings reveals numerous consistent and concordant conventional EEG and QEEG findings among studies within the same DSM (III & IV) diagnoses"[24].

Concerning Specific Learning Difficulties (SLD) and ADHD/ADD, Hughes and John state: "a large percentage of children with attention deficit problems (more than 90%) show QEEG signs of cortical dysfunction, the majority displaying frontal theta or alpha excess, hypercoherence and a high incidence of abnormal interhemispheric asymmetry. Using QEEG measures, it has been possible to discriminate replicably ADD/ADHD versus normal children with a specificity of 88% and a sensitivity of 94% and ADD versus SLD children with a sensitivity of 97% and a specificity of 84.2% [24]. Their conclusion is that "QEEG studies are particularly well suited to identifying subtle changes in the topographic distribution of background activity and can aid in difficult differential diagnoses such as assessing cognitive, attentional or developmental disorders" [24].

There is increasing consensus amongst brain researchers that many mental disorders are the result of disturbances in the rhythm of oscillations between the thalamus and the cortex in the brain. The dysregulation may, for the most part, be genetic in origin[6-9]. This view purports that thalamocortical oscillations are responsible for the timing and transfer of information between various structures in the brain, and that disruptions in their regulation are responsible for a wide range of psychiatric disorders [36-40]. The topometric QEEG is a valuable diagnostic tool because brain activity (driven by thalamocortical oscillations) is reflected in patterns of electrical activity at various parts of the cortex, and these patterns can be statistically analysed. It is a technique that has sufficient test-retest reliability for use in assessing clinical changes in cognitive status [45].

What is also not commonly known is that in many cases significant improvements or normalisation of ADHD symptoms can be achieved without the use of medication through EEG biofeedback (neurofeedback) [46]. Neurofeedback is based on the research of Professor M. Barry Sterman of the UCLA School of Medicine, Departments of Neurobiology and Behavioural Psychiatry. He recognised that rhythmic EEG properties and brain function could be altered and normalised by operant conditioning of the EEG [26, 36-37]. EEG biofeedback is an Applied Psychophysiology paradigm developed in the mid 70s, to train the brain to generate a brainwave pattern similar to or approach those of non-ADHD persons. Typically the brainwave training involves reinforcement of specific EEG frequencies while inhibiting others. During training sessions real-time QEEG is displayed on a computer in the form of a game, and the client is given contingent audio-visual rewards for producing the desired brainwave patterns. There is now significant evidence in the literature, which suggests that most ADHD children can learn to produce a brainwave pattern that is more normal [41-44]. This process empowers children to regulate their own brainwaves and behaviour, thus enhancing their self-esteem.

The training is believed to normalise the asymmetrical dopaminergic and noradrenegic neural control networks in the brain, and to help regulate sensorimotor integration. A complete discussion of the neurological underpinnings of ADHD and neurofeedback is beyond the scope of this article. However interested readers are invited to attend the SNR Conference being held in Sydney in August 2001 and/or refer to the references listed, in particular, "A Symphony in the Brain", by Jim Robbins [46].

Neurofeedback allows the therapist to address the physiological basis of behavioural problems without medication or in conjunction with medication. Thus, neurofeedback augments a pharmacological intervention in learning and behavioural disorders. Improvements in ADHD subjects following EEG biofeedback training correlate significantly with a number of empirical and subjective measures. Studies have shown improvement in impulsivity, attention, response time and variability of response time scores on Continuous Performance tests, such as the Test of Variables of Attention (TOVA). Additionally, reductions in hyperactivity and impulsivity on behaviour scales, increase in attention and cognitive skills in Individual Achievement Tests scores, and increases in IQ scores have also been shown [47-51]. Overall, results of several studies indicate that neurofeedback training is effective in over 80% of cases in significantly reducing the undesirable ADHD symptoms, and the effects appear to be lasting [52-56]. In many of the studies cited, the ADHD subjects were on psychostimulants at the start of the study. In those studies, where children were on medication, most of the subjects were able to reduce their stimulant medication or completely come off the medication by the end of training. These results are being replicated by neurofeedback practitioners in Australia.

A recent book by William Sears, a Paediatrician and former Assistant Professor at the University of Southern California School of Medicine and co-author Lynda Thompson, Director of the ADD Center in Toronto, outlines the current state of the clinical use of neurofeedback. They maintain that although neurofeedback studies to-date lack the power of double blind studies, there is sufficient valid research, to justify the mainstream clinical use of the treatment which teaches the brain to self-regulate [53].

The entire January 2000 edition of Clinical Electroencephalography, an authoritative peer-reviewed medical journal in the field of EEG, was devoted to neurofeedback. The Neurology Editor, Frank Duffy MD who directs the Clinical Neurophysiology Laboratory and Developmental Neurophysiology, a research Laboratory at the Children’s Hospital, Boston, which is affiliated with the Harvard Medical School stated in his editorial: "The literature which lacks any negative study of substance, suggests that EEG biofeedback should play a major therapeutic role in many difficult areas. In my opinion, if any medication had demonstrated such a wide spectrum of efficacy, it would be universally accepted and widely used"[57].

There have been growing concerns amongst medical practitioners and the general public over the use of psychostimulant medications in the treatment of ADHD. In this regard, neurologist John Hughes and psychiatrist Roy John have stated, "Medications that profoundly alter the availability of neurotransmitters and affect hypothesised pathophysiology are routinely prescribed by psychiatric practitioners. Nonetheless, little or no attempt is made in most cases, even in the treatment-resistant patient, to use biological assessment methods to select a treatment, to evaluate its physiological effect and to demonstrate its efficacy objectively" [24].

In January this year, a forty-week clinical trial to determine the effects of Ritalin on 312 severely afflicted ADHD children between the ages of three and eight years began at six different sites in America because, as Steven Hyman, director of the National Institute of Mental Health (NIHM) Rockville, USA stated: "it has been shown that more and more children in this age group are receiving this medication and we don’t have any idea about safe dose range or how it works over time" [58]. Although this trial raises obvious ethical and practical questions, Hyman maintains that it is necessary because without it "in essence every kid is an uncontrolled experiment—but we never learn anything"[58].

The topometric QEEG enables the practitioner to predict which medication and neurofeedback protocols are most appropriate and evaluate their effectiveness with a good degree of accuracy. The responsiveness of particular ADHD subtypes to psychostimulant medication can be predetermined in the majority of cases [59], "eliminating much of the hit and miss experimental approach prevalent in clinical practice" [60]. However, using effective diagnostic tools and pre-training measures as comparison data with post treatment measures, provides ethical, evidence-based practice.

In the last decade, neurofeedback has become progressively more popular in the amelioration of ADHD symptoms, partly due to advancements in technology which enable real-time EEG analysis and feedback. In 1995, The Yonkers School District, one of New York’s most socially disadvantaged areas, began using neurofeedback with its most difficult students. Some of the continued benefits include less teacher absenteeism, less student truancy, a decrease in aggressive and violent student behaviour together with more positive and academic outcomes for students with learning, attentional and behavioural difficulties [61]. In Australia, however, neurofeedback remains largely unrecognised or dismissed by mainstream professionals. The medical community continues to call for double-blind studies in EEG biofeedback. While this is an appropriate paradigm for drug testing, is inappropriate for use in this operant conditioning paradigm, for ethical and practical reasons.

As Daniel Amen, psychiatrist, so cogently writes in his book "Change your Brain, Change your Life", the brain is the "hardware of your soul" and as such "is the very essence of a human being" [15]. The early and accurate differential assessment of brain function and other physiological factors [20], together with EEG biofeedback, offer learning disabled and attention deficit children the opportunity for amelioration of their difficulties with all the life-enhancing and life-affirming progress this implies.


1.Australian Bureau of Statistics (ABS) website: http://www.abs.gov.au/Ausstats/A…/c188ff7c5bae661aca2568a900154a56!

2. Australian Social Trends 1999 Health Status: Mental Health. ABS Website.

3. SIEC Alert (2001): Children and Suicide. Suicide Information and Education Centre (SIEC) Calgary, Alberta, Canada.

4. Young adults most at risk of mental disorder- ABS Survey. ABS website

5. Australian Social Trends 1999 Health Status: Health & Socio-economic disadvantage of area. ABS Website

6. Blum, K. and J.E. Payne (1991). Alcohol and the addictive brain: New hope for alcoholics from biogenetic research.

7. Blum, K., et al.,( 1996 ): Reward Deficiency Syndrome. American Scientist, March-April: p. 1-14.

8. Blum, N.J. and M. Mercugliano, (1997) .Attention-deficit/hyperactivity disorder.

9. Miller, D. and K. Blum (1996): Overload: Attention Deficit Disorder and the addictive brain. Kansas: Andrews and McMeel.

10. Biederman, J., Faraone, S.V., Keenan, K. et al. (1992): "Further evidence for family- genetic risk factors in attention deficit hyperactivity disorder: Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically preferred samples". Archives of General Psychiatry . 49:728-738.

11. Semrud-Clikeman, M, Biederman, J, Sprich-Buckminster, S et al (1992): "Comorbidity between ADHD and learning disability: A review and report in a clinically referred sample". Journal of the American Academy of Child and Adolescent Psychiatry 31:439-448.

12. Shaywitz, BA, Shaywitz, SE, (1991):"Comorbidity : A critical issue in attention deficit disorder". Journal of Child Neurology. 6:s13-s20.

13. Wilens T, Biederman J, Mick E, Faraone S, Spencer T, (1997): "Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. Journal of Nervous and Mental Disorders. 185: 475-82.

14. Stordy, BJ & Nicholl (2000): The LCP Solution- The Remarkable Nutritional Treatment for ADHD, Dyslexia and Dyspraxia. BallantineBooks, New York.

15. Amen, DG (1998): Change your Brain Change your Life. Random House Inc. New York.

16. Weiss, G., Hechtman, L., Milroy, T., Perlman, T. (1985). Psychiatric Status of Hyperactives as Adults: A Controlled Prospective 15-Year Follow-up of 63 Hyperactive Children. Journal of the American Academy of Child Psychiatry. 24(2), 211-220.

17. Barkley, RA. (2001): Attention Deficit Hyperactivity Disorder :Workshop Manual, Sydney.

18. Hallowell, E.M. & Ratey J.J. (1994): Driven to Distraction- Recognising and Coping with Attention Deficit Disorder from Childhood through Adulthood. Touchstone.

19. Weiss, G., Hechtman, L, Perlman,T, Hopkins, J, Wehar, T (1979): "Hyperactives as young adults: A Controlled prospective ten-year follow-up of the psychiatric status of 75 children". Archives of General Psychiatry. 36, 675-681.

20. Lyon, MR (2000): Healing the Hyperactive Brain through the New Science of Functional Medicine. Focussed Publications, Canada

21. Barkley RA, & Cunningham, CE (1978): Do stimulant drugs improve academic performance of hyperkinetic children? A review of outcome research. Clinical Pediatrics.17, 85-92.

22. Swanson, J.M., et al., (1993) Effect of stimulant medication on children with attention deficit disorder: A "review of reviews." Special Issue: Issues in the education of children with attentional deficit disorder. Exceptional Children,. 60(2): p. 154-161.

23. Arnett, P.A., M. Fischer, and R.F. Newby, (1996). The effect of Ritalin on response to reward and punishment in children with ADHD. Child Study Journal, 26(1): p. 51-70.

24. Hughes, JR & Roy John, E (1999): Conventional and Quantitative Electroencephalography in Psychiatry. Journal of Neuropsychiatry and Clinical Neurosciences 11:190-208. May. American Psychiatric Press Inc.

25. American Psychiatric Association (1994): The Diagnostic and Statistical Manual of Mental Disorders – Fourth Edition (DSM IV). American Psychiatric Association, Washington D.C

26. Sterman, M.B (2000): EEG markers for attention deficit disorder: pharmacological and Neurofeedback applications. Child study Journal,. in press.

27. Lubar, J.F. and J.O. Lubar (1999.): Neurofeedback assessment and treatment for attention deficit/hyperactivity disorders.

28. Chabot, R.J. and G. Serfontain,( 1996): Quantitative electroencephalographic profiles of children with attention deficit disorder. Biological Psychiatry, Nov 15(10): p. 951-963

29.. Lubar, J.F. and J.O. Lubar, (1999): Neurofeedback assessment and treatment for attention deficit/hyperactivity disorders..

30..Loo, S. and B. Camp.( 1997): QEEG differences amongst ADHD children with and without Oppositional Behaviours. in Annual meeting of the Association for Applied Psychophysiology and Biofeedback.

31. Kuperman, S., et al., (1996) Quantitative EEG differences in a nonclinical sample of children with ADHD and undifferentiated ADD. Journal of the American Academy of Child and Adolescent Psychiatry,: p

32.. Chabot, R.J., et al., (1996) Sensitivity and specificity of QEEG in children with attention deficit or specific developmental learning disorders,. Clinical Electroencephalography. Jan; 27(1): p. 26-34.

33.. Clarke, A.R., et al.,( 1998) EEG Analysis in Attention-Deficit/Hyperactivity Disorder: a comparative study of two subtypes. Psychiatry Research,. 81 Oct 19(1): p. 19-29.

34. Amen, D.G. and B.D. Carmichael, (1997): High-resolution brain SPECT imaging in ADHD. Annals of Clinical Psychiatry,

35. Amen, DG (2001): Healing ADD- The breakthrough program that allows you to see and heal the 6 types of ADD. Putnam, NY.

36. Abarbanel, A., (1995): Gates, states, rhythms, and resonances: The scientific basis of Neurofeedback Training. Journal of Neurotherapy. 1(2): p. 15-38.

37.. Sterman, M.B.,(1996): Physiological origins and functional correlates of EEG rhythmic activities: Implications for self-regulation. Biofeedback and Self Regulation, 21(1): p. 3-33.

38. Othmer, S., S.F. Othmer, and D.A. Kaiser(1999.): EEG biofeedback: An emerging model for its global efficacy.

39. McCormick, D.A. (1999): Are thalamocortical oscillations the rosetta stone of a subset of neurological disorders. Nature Medicine, 5(12, Dec).

40. Llinas, R.R.,( 1999): Thalamocortical dysrhythmia. Proceedings of the National Academy of Sciences, 97: p. 15-222.

41. Lubar, J.F. (1997): Neocortical Dynamics: Implications for understanding the role of neurofeedback and related techniques for the enhancement of attention. Applied Psychophysiology and Biofeedback,. 22(2): p. 111-126

42.. Lubar, J.F (1995): Neurofeedback for Attention-Deficit Disorders, in Biofeedback: A practitioner's guide, M.S.a.A. Swartz, Editor. Guildford Press: New York. p. 493-522

43. Barabasz, A. and M. Barabasz,( 1996.): Neurotherapy and alert hypnosis in the treatment of attention deficit hyperactivity disorder.

44. Barabasz, M. and A. Barabasz, Attention deficit disorder: Diagnosis, etiology and treatment. Child Study Journal, 1996. 26(1): p. 1-37.

45. McEvoy, L.K., M.E. Smith, and A. Gevins (2000): Test-retest reliability of cognitive EEG. Clin Neurophysiol 2000 Mar 1;111(3):457-463,. 1,111(3): p. 457-463.

46. Robbins, J (2000): A Symphony in the Brain- The evolution of the New Brain Wave Biofeedback. Atlantic Monthly Press. NY.

47. Lubar, J.O. and J.F. Lubar(1984): Electroencephalographic biofeedback of SMR and beta for treatment of attention deficit disorders in a clinical setting. Biofeedback and Self Regulation, 9(1): p. 1-23.

48. Tansey, M.A., Wechsler (WISC--R) changes following treatment of learning disabilities via EEG biofeedback training in a private practice setting. Australian Journal of Psychology, 1991. 43(3): p. 147-153.

49. Linden, M., T. Habib, and V. Radojevic, A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities. Biofeedback and Self Regulation, 1996. 21(1): p. 35-49.

50. Carter, J.L. and H.L. Russell (1981): Changes in verbal-performance IQ discrepancy scores after left hemisphere EEG frequency control training: A pilot report. American Journal of Clinical Biofeedback, 4(1): p. 66-67.

51. Rossiter, T.R. and T.J. La Vaque (1995): A comparison of EEG biofeedback and psychostimulants in treating Attention Deficit Hyperactivity Disorders. Journal of Neurotherapy,.Summer: p. 48-59.

52. Lubar, J.F., Discourse on the development of EEG diagnostics and biofeedback for attention-deficit/hyperactivity disorders. Biofeedback and Self Regulation, 1991. 16(3): p. 201-225.

53. Sears, W. and L. Thompson ( 1998, ): The A.D.D. Book : New Understandings, New Approaches to Parenting your child. New York: Little, Brown & Company (Canada) Limited.

54. Lubar, J.F., et al. (1995), Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in T.O.V.A. scores, behavioral ratings, and WISC--R performance. Biofeedback and Self Regulation,. 20(1): p. 83-99.

55. Gaddes, W.H. and D. Edgell (1994): Learning Difficulties and Brain Functions. New York: Springer-Verlag.

56. Tansey, M.A., Ten-year stability of EEG biofeedback results for a hyperactive boy who failed fourth grade perceptually impaired class. Biofeedback and Self Regulation, 1993. 18(1): p. 33-44.

57. Duffy, F (2000): Neurotherapy: Editorial comments. Clinical Electroencephalography, Vol. 31, No.1, January.

58. Huget, J (2001): The Washington Post January 2, 2001. Page T06: Ritalin Study on Children.

For full article please see: http://washingtonpost.com/wp-dvn/articles/A64888-2000Dec29.html

59. Chabot, R.J., et al (1999): Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders. Journal of Child Neurology, 14(6): p. 343-351.

60. Duff, J (2001): Assessment and Neurotherapy treatment of ADHD. Behavioural Neurotherapy Clinic, Melbourne.

61. Sabo, J, Vagara, M (1998): The Yonkers Pilot Study. Presentation to the Winter Brain Conference, Palm Springs, California, USA. Full study currently in press, Journal of Neurotherapy Winter edition, 2001.

Assessments are by appointment only, for further information contact:-

Rosemary Boon


Telephone and Facsimile:
Sydney +61 2 9727 5794



P.O. Box 7120
Bass Hill NSW 2197